JP2017193503A - Deodorizing cosmetic - Google Patents
Deodorizing cosmetic Download PDFInfo
- Publication number
- JP2017193503A JP2017193503A JP2016084230A JP2016084230A JP2017193503A JP 2017193503 A JP2017193503 A JP 2017193503A JP 2016084230 A JP2016084230 A JP 2016084230A JP 2016084230 A JP2016084230 A JP 2016084230A JP 2017193503 A JP2017193503 A JP 2017193503A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- histidine
- component
- derivative
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 16
- 230000001877 deodorizing effect Effects 0.000 title abstract description 20
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims abstract description 42
- 229960002885 histidine Drugs 0.000 claims abstract description 21
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims abstract description 15
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims abstract description 15
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 11
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims abstract description 9
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229960002684 aminocaproic acid Drugs 0.000 claims abstract description 8
- 229960004949 glycyrrhizic acid Drugs 0.000 claims abstract description 8
- 235000019410 glycyrrhizin Nutrition 0.000 claims abstract description 8
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims abstract description 7
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims abstract description 6
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960003720 enoxolone Drugs 0.000 claims abstract description 6
- 239000000174 gluconic acid Substances 0.000 claims abstract description 6
- 235000012208 gluconic acid Nutrition 0.000 claims abstract description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims abstract description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 3
- 229960000458 allantoin Drugs 0.000 claims abstract description 3
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 6
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 6
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 6
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 6
- 229950006191 gluconic acid Drugs 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 238000002156 mixing Methods 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 229940079826 hydrogen sulfite Drugs 0.000 abstract description 2
- 238000004332 deodorization Methods 0.000 abstract 1
- BSAIUMLZVGUGKX-BQYQJAHWSA-N (E)-non-2-enal Chemical compound CCCCCC\C=C\C=O BSAIUMLZVGUGKX-BQYQJAHWSA-N 0.000 description 13
- BSAIUMLZVGUGKX-UHFFFAOYSA-N 2-Nonenal Natural products CCCCCCC=CC=O BSAIUMLZVGUGKX-UHFFFAOYSA-N 0.000 description 13
- 238000011156 evaluation Methods 0.000 description 13
- 235000019645 odor Nutrition 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 230000032683 aging Effects 0.000 description 7
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000019766 L-Lysine Nutrition 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 229940009662 edetate Drugs 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000010525 oxidative degradation reaction Methods 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- WDCYWAQPCXBPJA-UHFFFAOYSA-N 1,3-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC([N+]([O-])=O)=C1 WDCYWAQPCXBPJA-UHFFFAOYSA-N 0.000 description 1
- HORQAOAYAYGIBM-UHFFFAOYSA-N 2,4-dinitrophenylhydrazine Chemical compound NNC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HORQAOAYAYGIBM-UHFFFAOYSA-N 0.000 description 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- GFNYZEJAMGHBHB-ZSCHJXSPSA-N C(C=CCCCCCC)=O.N[C@@H](CC1=CNC=N1)C(=O)O Chemical compound C(C=CCCCCCC)=O.N[C@@H](CC1=CNC=N1)C(=O)O GFNYZEJAMGHBHB-ZSCHJXSPSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Abstract
Description
本発明は、加齢臭の主な原因物質とされる２−ノネナールを消臭する化粧料に関する。さらに詳しくは、本発明は、高い消臭効果を発揮し、また、消臭効果を損なうことなく安定して発揮することのできる化粧料に関する。
The present invention relates to a cosmetic that deodorizes 2-nonenal, which is a main causative substance of an aging odor. More specifically, the present invention relates to a cosmetic that exhibits a high deodorizing effect and that can be stably exhibited without impairing the deodorizing effect.
近年、加齢に伴い身体や頭部から発生する臭いに対してのケアに注目が集まってきており、それらの臭いを炭などの多孔性物質が吸着することにより除去する技術（特許文献１）や原因となる常在菌の繁殖を抑制する技術（特許文献２）、香料成分などでマスキングする技術、ブドウ糖と特定のアミノ酸で消臭化する技術（特許文献３）などが開発されている。このような加齢に伴った不快な臭いは一般的に加齢臭と呼ばれており、夏場の汗臭などとともに不快なものとされ、解消が求められている。 In recent years, attention has been focused on the care for odors generated from the body and head with aging, and a technique for removing these odors by adsorption of a porous substance such as charcoal (Patent Document 1). In addition, a technique for suppressing the propagation of resident bacteria that cause the disease (Patent Document 2), a technique for masking with a fragrance component, etc., a technique for debromating with glucose and a specific amino acid (Patent Document 3), and the like have been developed. Such an unpleasant odor accompanying aging is generally called an aging odor, and it is considered unpleasant with a sweat odor in summer and is required to be solved.
その一方で、加齢臭の主な原因物質として２−ノネナールが提唱されており、この成分は加齢とともに増大することが示されている。特に加齢臭が発生する年齢とされる４０歳以降で顕著に増大することが確認されている。２−ノネナールはω７不飽和脂肪酸の酸化的分解によって発生し、過酸化脂質がその酸化的分解を促進することが示されている。
発生した２−ノネナールを消臭する物質については、Ｌ−ヒスチジンに極めて高い２−ノネナールの消臭効果があることが知られている。しかし、Ｌ−ヒスチジンは特定の化合物と併用した場合、著しく消臭効果が低減し、安定性も経時的に減少する事が問題点であった。
On the other hand, 2-nonenal has been proposed as a main causative substance of an aging odor, and this component has been shown to increase with aging. In particular, it has been confirmed that it significantly increases after the age of 40, which is the age at which an aging odor occurs. 2-nonenal is generated by oxidative degradation of ω7 unsaturated fatty acids, and lipid peroxide has been shown to promote its oxidative degradation.
Regarding substances that deodorize the generated 2-nonenal, it is known that L-histidine has a very high 2-nonenal deodorizing effect. However, when L-histidine is used in combination with a specific compound, the deodorizing effect is remarkably reduced and the stability is also decreased over time.
本発明は、Ｌ−ヒスチジンの消臭効果および安定性が特定の化合物：成分（Ｃ）との共存時に著しく低下する現象に対し、これを改善した化粧料を提供することを目的とする。
An object of the present invention is to provide a cosmetic that improves the deodorizing effect and stability of L-histidine against a phenomenon in which the deodorizing effect and stability of the L-histidine are significantly reduced when coexisting with a specific compound: component (C).
以上の問題を解決するため、本発明者が鋭意検討した結果、Ｌ−ヒスチジンの成分（Ｃ）による消臭効果および安定性の低下が、ピロ亜硫酸塩、亜硫酸塩、亜硫酸水素塩を用いることで改善することを見出した。さらにこれら３成分を組み合わせることによって、製剤の経時安定化についても相乗的に効果が上昇することが判明した。
As a result of intensive studies by the present inventors in order to solve the above problems, the deodorizing effect and the stability decrease due to the component (C) of L-histidine are reduced by using pyrosulfite, sulfite, and bisulfite. Found to improve. Furthermore, it has been found that combining these three components synergistically increases the stability of the formulation over time.
すなわち本発明は
次の成分（Ａ）〜（Ｃ）、
（Ａ）Ｌ−ヒスチジン
（Ｂ）ピロ亜硫酸塩、亜硫酸塩、亜硫酸水素塩から選択される１種又は２種以上
（Ｃ）グリチルリチン酸、グリチルリチン酸の誘導体、及びグリチルリチン酸の塩、グリチルレチン酸、グリチルレチン酸の誘導体、及びグリチルレチン酸の塩、ε−アミノカプロン酸、ε−アミノカプロン酸の誘導体、及びε−アミノカプロン酸の塩、グルコン酸、グルコン酸の誘導体、及びグルコン酸の塩、アラントイン及びアラントインの誘導体から選択される１種又は２種以上
を含有する化粧料である。
That is, the present invention includes the following components (A) to (C),
(A) L-histidine (B) one or more selected from pyrosulfite, sulfite, bisulfite (C) glycyrrhizic acid, a derivative of glycyrrhizic acid, and a salt of glycyrrhizic acid, glycyrrhetinic acid, glycyrrhetin Derivatives of acids, and salts of glycyrrhetinic acid, ε-aminocaproic acid, ε-aminocaproic acid, and ε-aminocaproic acid, gluconic acid, gluconic acid, and gluconic acid salts, allantoin and allantoin derivatives It is a cosmetic containing one or more selected.
本発明によれば、Ｌ−ヒスチジンを用いた消臭化粧料について、Ｌ−ヒスチジンの消臭効果および安定性が特定の成分、成分（Ｃ）の配合時に低下するのを、効果的に防ぐことが可能となる。 According to the present invention, for deodorant cosmetics using L-histidine, the deodorizing effect and stability of L-histidine are effectively prevented from decreasing when the specific component, component (C) is blended. Is possible.
以下、本発明について更に詳しく説明する。 Hereinafter, the present invention will be described in more detail.
本発明に用いられる成分（Ａ）Ｌ−ヒスチジンは、本発明において２−ノネナールを消臭するために配合している。 Component (A) L-histidine used in the present invention is blended in the present invention to deodorize 2-nonenal.
本発明に用いられる成分（Ａ）Ｌ−ヒスチジンは望ましくは０．０１％〜５％が望ましい。さらに望ましくは０．１％〜３％が望ましい。 Component (A) L-histidine used in the present invention is desirably 0.01% to 5%. More preferably, the content is 0.1% to 3%.
本発明に用いられる成分（Ｂ）ピロ亜硫酸塩、亜硫酸塩、亜硫酸水素塩は、これらに成分（Ａ）と成分（Ｃ）とを共に配合することで、偶然にも成分（Ａ）の消臭効果が効果的に保持できた。塩の種類は特に限定されず、成分（Ｂ）は還元能を有する成分であることが望ましい。 The component (B) pyrosulfite, sulfite, and hydrogen sulfite used in the present invention, together with the component (A) and the component (C), accidentally deodorizes the component (A). The effect could be maintained effectively. The kind of salt is not particularly limited, and component (B) is preferably a component having reducing ability.
本発明に用いられる成分（Ｂ）は望ましくは０．００１％〜１％が望ましい。さらに望ましくは０．０１％〜０．１％が望ましい。 The component (B) used in the present invention is desirably 0.001% to 1%. More desirably, the content is 0.01% to 0.1%.
本発明に用いられる成分（Ｃ）に挙げた成分は化粧品添加物として、医薬部外品の有効成分、添加物として一般的に汎用されている成分であり、抗炎症効果や肌荒れ防止効果などを目的にスキンケア、トイレタリー製品などに幅広く配合される。 Ingredients (C) used in the present invention are ingredients that are commonly used as cosmetic additives, quasi-drug active ingredients, and additives, and have anti-inflammatory effects and rough skin prevention effects. Widely used in skin care and toiletry products for purposes.
成分（Ｃ）の塩の種類、誘導体の種類は特に限定されず、成分の母体構造が共通していれば成分（Ａ）の消臭効果及び安定性を損ない、損なわれた効果や安定性が成分（Ｂ）の存在時に改善した。 The kind of the salt of component (C) and the kind of derivative are not particularly limited. If the matrix structure of the component is common, the deodorizing effect and stability of component (A) are impaired, and the impaired effect and stability are reduced. Improved in the presence of component (B).
本発明の皮膚洗浄用組成物は液状、ペースト状、クリーム状、およびジェル状など剤型には寄らず適用することができる。
The skin cleansing composition of the present invention can be applied regardless of the dosage form such as liquid, paste, cream, and gel.
以下に実施例を挙げて、本発明を更に説明する。なお、これらは本発明を何ら限定するものではない。配合量は組成物全量に対する質量％である。 The following examples further illustrate the present invention. In addition, these do not limit this invention at all. A compounding quantity is the mass% with respect to the composition whole quantity.
本実施例で用いた評価項目について説明する。
１．「消臭効果（分析）」
「評価方法」
２−ノネナール除去能の評価は、ＨＰＬＣを利用した測定方法（分析化学, ４６(１) , ３１-３６, １９９７）を改変して２−ノネナールの量を測定することにより行った。
Evaluation items used in this example will be described.
1. "Deodorizing effect (analysis)"
"Evaluation method"
Evaluation of 2-nonenal removal ability was performed by measuring the amount of 2-nonenal by modifying a measurement method using HPLC (Analytical Chemistry, 46 (1), 31-36, 1997).
実施例もしくは比較例の化粧料を、９５％エタノール水溶液を溶媒として５０％溶液として試料とした。
陽性対象には、２−ノネナールの除去効果が知られているＬ−リジン（特開２０１１−１
５６２２７）と、同じ塩基性アミノ酸のＬ−ヒスチジンを用いた。Ｌ−リジンは５０％エ
タノール水溶液を溶媒として１％溶液とし、Ｌ−ヒスチジンは１％水溶液を調整し、試験に用いた。
The cosmetics of Examples or Comparative Examples were used as samples with a 95% ethanol aqueous solution as a solvent and a 50% solution.
For positive subjects, L-lysine (Japanese Unexamined Patent Publication No. 2011-1), which is known to have a removal effect of 2-nonenal.
56227) and the same basic amino acid L-histidine was used. L-lysine was prepared as a 1% solution using a 50% ethanol aqueous solution as a solvent, and L-histidine was used in the test after preparing a 1% aqueous solution.
上記試料又は陽性対照であるＬ−リジン溶液、又はＬ‐ヒスチジン溶液を５００μＬと、９５％エタノールを溶媒として調製した５μＭ２‐ノネナール溶液５００μＬとを混合後、３２℃の恒温槽で８時間温めた。Ｃｏｎｔｒｏｌには試料の代わりに９５％エタノール水溶液を用いた。その後ＤＮＰＡ液５００μLを混合後、４５℃の恒温槽で３０ｍｉｎ反応させた（反応液）。ＤＮＰＡ液とは、ＤＮＰＨ（２，４‐Ｄｉｎｉｔｒｏｐｈｅｎｙｌ ｈｙｄｒａｚｉｎｅ Ｈｙｄｒｏｃｈｌｏｒｉｄｅ) ２５ｍｇ, ９９.５％エタノール４５ｍＬ, 濃塩酸１ｍＬ, 蒸留水 ４ｍＬの混合液を指す。反応液は 氷水で約１０ｍｉｎ冷却し、反応を停止させた。反応を停止させた反応液はろ過後、ＨＰＬＣにて解析を行った。２-ノネナールの検出はリテンションタイム１１．５ｍｉｎに確認された。体臭成分である２‐ノネナールの除去率は、以下の式に従いピーク面積から求めた。 500 μL of the L-lysine solution or L-histidine solution, which is the sample or the positive control, was mixed with 500 μL of a 5 μM 2-nonenal solution prepared using 95% ethanol as a solvent, and then heated in a constant temperature bath at 32 ° C. for 8 hours. A 95% ethanol aqueous solution was used for Control instead of the sample. Thereafter, 500 μL of DNPA solution was mixed and reacted in a 45 ° C. constant temperature bath for 30 min (reaction solution). The DNPA liquid refers to a mixed solution of 25 mg of DNPH (2,4-dinitrophenyl hydride), 45 mL of 99.5% ethanol, 1 mL of concentrated hydrochloric acid, and 4 mL of distilled water. The reaction solution was cooled with ice water for about 10 minutes to stop the reaction. The reaction solution whose reaction was stopped was filtered and analyzed by HPLC. The detection of 2-nonenal was confirmed at a retention time of 11.5 min. The removal rate of 2-nonenal, which is a body odor component, was determined from the peak area according to the following formula.
＜式１＞
＜ＨＰＬＣ 条件＞
カラム； ＣＨＥＭＣＯＢＯＮＤ ５−ＯＤＳ−Ｗ ｓｉｚｅ６．０×１５０ (６Ａ)
流速 ； １.５ ｍＬ／ｍｉｎ
カラム温度 ； ５０ ℃
移動相 ； ＣＨ３ＣＮ：Ｈ２Ｏ ＝ ８０:２０（ Ｖ/Ｖ）
検出器/測定波長 ；紫外可視検出器／３６５ ｎｍ
<HPLC conditions>
Column; CHEMCOBOND 5-ODS-W size 6.0 × 150 (6A)
Flow rate: 1.5 mL / min
Column temperature: 50 ° C
Mobile phase: CH3CN: H2O = 80: 20 (V / V)
Detector / measurement wavelength: UV-visible detector / 365 nm
「評価基準」
上記方法でＬ−ヒスチジンの２−ノネナールの除去率によって以下のように評価した。
○：除去率８０％以上
△：除去率４０％以上、８０％未満
×：除去率１％以上、４０％未満
××：除去率１％未満
"Evaluation criteria"
According to the above method, the removal rate of L-histidine 2-nonenal was evaluated as follows.
○: Removal rate 80% or more Δ: Removal rate 40% or more, less than 80% ×: Removal rate 1% or more, less than 40% XX: Removal rate less than 1%
２．「消臭効果（官能）」
「評価方法」
実施例もしくは比較例の化粧料を、水を溶媒として５０％溶液として試料とした。陰性対照として水を用いた。１０μＭ２−ノネナール溶液と試料を１：１の割合で混合し、１０分後のにおいを評価することによって確認した。なお、評価は熟練の評価者５名で行った。
「評価基準」
上記試験結果から、各試料と混合した溶液のにおいに以下のようにスコアをつけた。
５点：においなし
４点：ほとんどにおいなし
３点：においは低減しているが残っている
２点：わずかににおいが減っている
１点：変化なし
続いて評価者５名の平均スコアを算出し、以下のように評価を行った。
○：４点以上
△：２点以上４点未満
×：２点未満
2. "Deodorizing effect (sensory)"
"Evaluation method"
The cosmetics of Examples or Comparative Examples were used as samples in a 50% solution using water as a solvent. Water was used as a negative control. It confirmed by mixing 10 micromol 2-nonenal solution and a sample by the ratio of 1: 1, and evaluating the smell after 10 minutes. The evaluation was performed by five skilled evaluators.
"Evaluation criteria"
From the test results, the odor of the solution mixed with each sample was scored as follows.
5 points: No odor 4 points: Almost no odor 3 points: Odor is reduced but remaining 2 points: Slightly reduced odor 1 point: No change Subsequently, average score of 5 evaluators is calculated Then, evaluation was performed as follows.
○: 4 points or more Δ: 2 points or more and less than 4 points ×: Less than 2 points
３.「安定性」
「評価方法」
実施例および比較例の化粧料を６０℃下に１週間静置し、熟練の評価者が外観の経時変化を目視により確認することで評価を行った。
「評価基準」
上記方法により経時変化を確認し、経時変化の度合いにより以下のように評価を行った。
○：変化なし
×：黄色に変色している。
3. “Stability”
"Evaluation method"
The cosmetics of the examples and comparative examples were allowed to stand at 60 ° C. for 1 week, and evaluation was performed by a skilled evaluator confirming the appearance change with time by visual observation.
"Evaluation criteria"
The change with time was confirmed by the above method, and evaluation was performed as follows according to the degree of change with time.
○: No change ×: Discolored to yellow.
比較例２、３、および７〜９を参照すると、成分（Ａ）と成分（Ｃ）が共存することにより、消臭効果、安定性共に非常に悪いことが伺える。これに対し、実施例を参照すると、成分（Ｂ）が配合された場合、消臭効果、安定性共に非常に良好である。 Referring to Comparative Examples 2, 3, and 7 to 9, it can be seen that the component (A) and the component (C) coexist so that both the deodorizing effect and the stability are very poor. On the other hand, when an Example is referred, when a component (B) is mix | blended, both a deodorizing effect and stability are very favorable.
実施例１、２、３では成分Ｂの配合量を変化させているが、０．００１％でも十分な効果が得られていることが分かる。また、実施例４に示したとおり成分Ａの配合量が０．０１％でも十分な消臭効果が得られていることが分かる。 In Examples 1, 2, and 3, although the compounding quantity of the component B was changed, it turns out that sufficient effect is acquired even if it is 0.001%. Further, as shown in Example 4, it can be seen that a sufficient deodorizing effect is obtained even when the blending amount of Component A is 0.01%.
なお、安定性の評価において色調の変化が起こっているものは、使用感にも変動が起きている傾向があり、成分（Ａ）、成分（Ｂ）及び成分（Ｃ）が共存することにより、使用感の変化を抑える利点も確認された。 In addition, in the evaluation of stability, the change in color tone tends to have a change in the feeling of use, and when the component (A), the component (B) and the component (C) coexist, The advantage of suppressing changes in the feeling of use was also confirmed.
以上の結果から、処方に成分（Ｃ）を配合する際に、成分（Ａ）を用いて消臭効果を付与したい場合は、成分（Ｂ）を組み合わせて配合することで、より高い消臭効果と安定性を付与することができる。 From the above results, when blending the component (C) in the prescription, if it is desired to impart a deodorizing effect using the component (A), a higher deodorizing effect can be obtained by combining the components (B). And stability can be imparted.
常法にて、各処方の組成物を作製した。いずれの処方においても本発明の効果を奏することが確認された。
（１）シャンプー
配合成分 配合量（％）
水 残量
Ｌ−ヒスチジン ０．３
亜硫酸Ｎａ ０．０５
グリチルリチン酸２Ｋ ０．１０
塩化Ｎａ 適量
ｐＨ調整剤 適量
防腐剤 適量
グリセリン ８．００
エデト酸塩 ０．０５
ラウレス硫酸Ｎａ １２．００
ＰＰＧ−２コカミド ２．００
ラウリルヒドロキシスルタイン ３．００
ポリクオタニウムー１０ ０．０５
合計（％） １００．００
The composition of each prescription was produced by the conventional method. It was confirmed that the effects of the present invention were achieved in any prescription.
(1) Shampoo compounding ingredients Compounding amount (%)
Water remaining L-histidine 0.3
Sulfite Na 0.05
Glycyrrhizic acid 2K 0.10
Sodium chloride appropriate amount pH adjuster appropriate amount preservative appropriate amount glycerin 8.00
Edetate 0.05
Laureth sulfate Na 12.00
PPG-2 cocamide 2.00
Lauryl hydroxysultain 3.00
Polyquaternium-10 0.05
Total (%) 100.00
（２）化粧水
配合成分 配合量（％）
水 残量
Ｌ−ヒスチジン ０．１５
亜硫酸Ｎａ ０．０５
グリチルリチン酸２Ｋ ０．１０
エタノール ４０．００
ｐＨ調整剤 適量
防腐剤 適量
１，３−ＢＧ ８．００
エデト酸塩 ０．０１
Ｌ−メントール ０．２０
合計（％） １００．００
(2) Toner lotion ingredients Amount (%)
Water remaining L-histidine 0.15
Sulfite Na 0.05
Glycyrrhizic acid 2K 0.10
Ethanol 40.00
pH adjuster appropriate amount preservative appropriate amount 1,3-BG 8.00
Edetate 0.01
L-Menthol 0.20
Total (%) 100.00
Claims (3)
（Ａ）Ｌ−ヒスチジン
（Ｂ）ピロ亜硫酸塩、亜硫酸塩、亜硫酸水素塩から選択される１種又は２種以上
（Ｃ）グリチルリチン酸、グリチルリチン酸の誘導体、及びグリチルリチン酸の塩、グリチルレチン酸、グリチルレチン酸の誘導体、及びグリチルレチン酸の塩、ε−アミノカプロン酸、ε−アミノカプロン酸の誘導体、及びε−アミノカプロン酸の塩、グルコン酸、グルコン酸の誘導体、及びグルコン酸の塩、アラントイン及びアラントインの誘導体から選択される１種又は２種以上
を含有する化粧料。
The following components (A) to (C),
(A) L-histidine (B) one or more selected from pyrosulfite, sulfite, bisulfite (C) glycyrrhizic acid, a derivative of glycyrrhizic acid, and a salt of glycyrrhizic acid, glycyrrhetinic acid, glycyrrhetin Derivatives of acids, and salts of glycyrrhetinic acid, ε-aminocaproic acid, ε-aminocaproic acid, and ε-aminocaproic acid, gluconic acid, gluconic acid, and gluconic acid salts, allantoin and allantoin derivatives Cosmetics containing one or more selected.
成分（Ａ）Ｌ−ヒスチジンの配合量が０．０１％〜５％
成分（Ｂ）の配合量が０．００１％〜１％
である請求項１記載の化粧料。
The following components (A) to (C),
Component (A) L-histidine content is 0.01% to 5%
Component (B) content is 0.001% to 1%
The cosmetic according to claim 1, wherein
The cosmetic according to claim 1, which is a cleaning cosmetic.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016084230A JP6534958B2 (en) | 2016-04-20 | 2016-04-20 | Deodorant cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016084230A JP6534958B2 (en) | 2016-04-20 | 2016-04-20 | Deodorant cosmetic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017193503A true JP2017193503A (en) | 2017-10-26 |
| JP6534958B2 JP6534958B2 (en) | 2019-06-26 |
Family
ID=60155815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016084230A Active JP6534958B2 (en) | 2016-04-20 | 2016-04-20 | Deodorant cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6534958B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017193502A (en) * | 2016-04-20 | 2017-10-26 | 株式会社ナリス化粧品 | Deodorizing cosmetic |
| JP2017193504A (en) * | 2016-04-20 | 2017-10-26 | 株式会社ナリス化粧品 | Deodorizing cosmetic |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014193254A (en) * | 2013-03-29 | 2014-10-09 | Kagawa Univ | Washing method for fiber product |
| JP2015168615A (en) * | 2014-03-04 | 2015-09-28 | 持田製薬株式会社 | Composition for cleaning |
-
2016
- 2016-04-20 JP JP2016084230A patent/JP6534958B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014193254A (en) * | 2013-03-29 | 2014-10-09 | Kagawa Univ | Washing method for fiber product |
| JP2015168615A (en) * | 2014-03-04 | 2015-09-28 | 持田製薬株式会社 | Composition for cleaning |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017193502A (en) * | 2016-04-20 | 2017-10-26 | 株式会社ナリス化粧品 | Deodorizing cosmetic |
| JP2017193504A (en) * | 2016-04-20 | 2017-10-26 | 株式会社ナリス化粧品 | Deodorizing cosmetic |
Also Published As
| Publication number | Publication date |
|---|---|
| JP6534958B2 (en) | 2019-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001085156A1 (en) | Dermal compositions containing coenzyme q as the active ingredient | |
| JP4567732B2 (en) | Skin cosmetics and wrinkle improvers | |
| JP6474963B2 (en) | Cleaning composition | |
| JP6534958B2 (en) | Deodorant cosmetic | |
| JP5695678B2 (en) | Deodorant containing polyhydric alcohol | |
| JP6752607B2 (en) | Deodorant cosmetics | |
| JPH11286423A (en) | Composition for suppressing body odor | |
| JP2018524277A (en) | Deodorant composition comprising a mixture of α-, β- and γ-cyclodextrin | |
| JP2003176217A (en) | Skin care preparation | |
| JP4589236B2 (en) | Cosmetics | |
| JP2016088925A (en) | External composition for skin | |
| JP6571041B2 (en) | Deodorant cosmetic | |
| EP3603610B1 (en) | Trpa1 activity inhibitor | |
| JP5061984B2 (en) | Adapalene-containing external preparation composition | |
| KR20200141046A (en) | Topical formulations and methods of treatment comprising strontium and methylsulfonylmethane (MSM) | |
| JP2014047165A (en) | Composition for washing | |
| JP2019081763A (en) | Cleaning composition | |
| JPS649965B2 (en) | ||
| JPS61176510A (en) | Skin-beautifying cosmetic | |
| JPH11286425A (en) | Composition for suppressing aged person smell | |
| JP6534957B2 (en) | Chlorine remover and skin external preparation | |
| JP4488933B2 (en) | Wrinkle improving agent and external composition for skin | |
| JPH07112966B2 (en) | Skin cosmetics | |
| JP6125818B2 (en) | Liquid oral composition | |
| JP2019019103A (en) | Deodorant liquid detergent composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180323 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190125 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190305 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190528 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190530 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6534958 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |